Cancer BiologybioRxivPreprint
Genetically modified IL-2 bone marrow-derived myeloid cells reprogram the glioma immunosuppressive tumormicroenvironment
A. Canella, M. Nazzaro, S. Rajendran…·P. Rajappa
This study shows that genetically modified myeloid cells releasing IL-2 can reprogram the glioma tumor microenvironment to enhance anti-tumor immunity in a mouse model.
DOI 10.1101/2022.10.19.511786